SLCO1B3 genotype

US10094836B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• William D. Figg · Fairfax, US
• Alex Sparreboom · Memphis, US
• Akinobu HAMADA · Tokyo, JP
• Douglas K. Price · Fairfax, US
• Tristan M. Sissung · Annandale, US

Key dates

• Filing date: Jan 8, 2008
• Grant date: Oct 9, 2018
• Expiry date: Jun 20, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/172
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention relates methods of identifying and predicting inter-patient differences in prognostic prediction for survival in androgen independent prostate cancer. It further related to methods for determining and exploiting such differences to improve medical outcomes. Moreover, it provides methods for determining if a subject has prostate cancer.